
Program Organizing Committee
Kristien Boelaert, MD, PhD – Co-Chair
University of Birmingham
Elizabeth Ellen Cottrill, MD – Co-Chair
Thomas Jefferson University
Sara Ahmadi, MD – Steering Committee
Hospital Brigham and Women’s Hospital
Nicholas E. Bambach – Steering Committee
University of Pennsylvania
Sheue-yann Cheng, PhD – Steering Committee
National Cancer Institute / National Institutes of Health
Abbey L. Fingeret, MD – Steering Committee
University of Nebraska Medical Center
Maya B. Lodish, MD – Steering Committe
University of California, San Francisco
Zoltan Antal, MD
Memorial Sloan Kettering Cancer Center
Kaniksha Shekhar Desai, MD
Stanford University
Sina A. Jasim, MD
Washington University in St. Louis
Salma Khan, MD, PhD
Loma Linda University
Sarah Catherine Oltmann, MD, FACS
University of Texas Southwestern
Martin Lucas Read, PhD
University of Birmingham
Federico Salas-Lucia, PhD
University of Chicago
Steven I. Sherman, MD
The University of Texas MD Anderson Cancer Center
David C. Shonka, Jr., MD
University of Virginia
Thomas Szabo Yamashita, MD
Emory School of Medicine
Jacqueline Jonklaas, MD, PhD – Board Liaison
Georgetown University Medical Center
A Message from our Program Co-Chairs:
We are pleased to invite you to join us at the ATA Annual Meeting in Scottsdale, Arizona, over the dates, September 10-14, 2025.
We have designed the program to offer the latest clinical content and scientific research, while including updates on the ATA’s guidelines. Choose from a variety of sessions in basic science, endocrinology, surgery, and thyroid cancer. New this year we will feature a Core Thyroidology track to highlight foundational biology for attendees across all career stages and a joint session with the Society of Nuclear Medicine and Molecular Imaging.
Always a cornerstone of the program the plenary sessions each day will highlight topics including the popular Year-in-Thyroidology and presentations from the 2025 ATA Award winners. Throughout the meeting you will have opportunities to network and meet colleagues, engage with our trainees and early career members, and join the Saturday night closing party.
Be sure to visit the exhibit hall for a variety of events. Learn about the latest products and services available from our corporate partners. View multiple daily poster sessions. Check out a full schedule of events in the Expo Theater. And back by popular demand, an opening night welcome reception, along with themed morning and afternoon refreshment breaks.
We look forward to welcoming you to the 2025 Annual Meeting. See you in Scottsdale!
Sincerely,
Elizabeth Cottrill, MD
Kristien Boelaert, MD, PhD, FRCP
2025 Program Co-Chairs
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the American Thyroid Association and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The American Thyroid Association has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
American Thyroid Association staff associated with the development of content for this activity reported no relevant financial relationships.